Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans
- PMID: 4031039
- PMCID: PMC268371
- DOI: 10.1128/jcm.22.2.259-264.1985
Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans
Abstract
Serum and nasal wash specimens from 13 human volunteers undergoing experimental secondary infection with influenza A/Peking/2/79 (H3N2) wild-type virus were examined for the molecular form and subclass distribution of immunoglobulin A (IgA) antibodies to the viral hemagglutinin (HA). Nasal IgA antibodies were polymeric and did not bind radiolabeled secretory component, indicating that they were secretory IgA antibodies. Both IgA1 and IgA2 antibodies were detected; however, IgA1 accounted for most of the rise in IgA anti-HA levels seen after infection. In serum virtually all of the IgA HA antibodies were of the IgA1 subclass. Furthermore, the serum antibodies were predominantly polymeric and were capable of binding radiolabeled secretory component. These results suggested that the serum IgA antibodies to HA were of mucosal origin and that influenza A virus HA preferentially stimulates an IgA1 response.
Similar articles
-
Immunoglobulins in nasal secretions of healthy humans: structural integrity of secretory immunoglobulin A1 (IgA1) and occurrence of neutralizing antibodies to IgA1 proteases of nasal bacteria.Clin Diagn Lab Immunol. 2000 Jan;7(1):31-9. doi: 10.1128/CDLI.7.1.31-39.2000. Clin Diagn Lab Immunol. 2000. PMID: 10618273 Free PMC article.
-
Induction and molecular properties of secretory and serum IgA antibodies specific for environmental antigens.Ann Allergy. 1987 Nov;59(5 Pt 2):54-9. Ann Allergy. 1987. PMID: 3318587 Review.
-
Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus.Infect Immun. 1983 Aug;41(2):540-5. doi: 10.1128/iai.41.2.540-545.1983. Infect Immun. 1983. PMID: 6874068 Free PMC article.
-
Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.Infect Immun. 1982 Jun;36(3):1102-8. doi: 10.1128/iai.36.3.1102-1108.1982. Infect Immun. 1982. PMID: 7095844 Free PMC article.
-
Immunobiology of IgA.Am J Kidney Dis. 1988 Nov;12(5):378-83. doi: 10.1016/s0272-6386(88)80029-5. Am J Kidney Dis. 1988. PMID: 3055962 Review.
Cited by
-
Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.J Clin Microbiol. 1986 Jan;23(1):66-72. doi: 10.1128/jcm.23.1.66-72.1986. J Clin Microbiol. 1986. PMID: 3700610 Free PMC article.
-
Class and subclass-associated specificity differences of anti-gliadin antibodies from mucosa and serum.Immunology. 1992 Dec;77(4):604-8. Immunology. 1992. PMID: 1493932 Free PMC article.
-
Comparative efficacy of intranasal and injectable vaccines in stimulating Bordetella bronchiseptica-reactive anamnestic antibody responses in household dogs.Can Vet J. 2017 Aug;58(8):809-815. Can Vet J. 2017. PMID: 28761185 Free PMC article.
-
Challenges to the Effectiveness and Immunogenicity of COVID-19 Vaccines: A Narrative Review with a Systematic Approach.Vaccines (Basel). 2025 Jul 24;13(8):789. doi: 10.3390/vaccines13080789. Vaccines (Basel). 2025. PMID: 40872876 Free PMC article. Review.
-
The Future of Flu: A Review of the Human Challenge Model and Systems Biology for Advancement of Influenza Vaccinology.Front Cell Infect Microbiol. 2019 Apr 17;9:107. doi: 10.3389/fcimb.2019.00107. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31065546 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous